Bmr Ent., Inc.

Bmr Ent., Inc. specializes in neurostimulation devices, specifically systems like the NT2000 and NT4-PLUS. These devices are engineered for targeted neural modulation, which is used in therapeutic applications to influence nerve activity for medical treatment purposes.

Bmr Ent., Inc. is headquartered in the United States. The company’s location is relevant for regulatory compliance and device distribution, particularly when navigating FDA requirements for Class II devices.

Bmr Ent., Inc.’s devices, such as the NT2000 and NT4-PLUS, fall under Class II classification by the FDA. This classification is determined by the level of risk associated with the device’s intended use and design. Class II devices require special controls beyond general controls to ensure safety and effectiveness, which is why they must go through the 510(k) clearance process before commercialization.

Bmr Ent., Inc.’s devices are listed in the FDA’s 510(k) clearance registry. This registry documents that the devices have undergone the required premarket notification process to demonstrate substantial equivalence to a legally marketed predicate device, ensuring compliance with FDA regulations before they enter the market.